{"id":"W2519097826","doi":"10.1111/cei.12866","title":"Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies","year":2016,"lang":"en","type":"article","venue":"Clinical & Experimental Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Baxalta","keywords":"Tolerability; Medicine; Adverse effect; Pharmacokinetics; Incidence (geometry); Internal medicine; Antibody; Gastroenterology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00106598,0.0005123921,0.001420441,0.0002743632,0.0001953337,0.00001468925,0.0007199176,0.0003548433,0.0002241259],"category_scores_gemma":[0.0002439425,0.0003740713,0.0001401695,0.0005825026,0.002661276,0.0001989798,0.0006776671,0.0006884622,0.00003304815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001462202,"about_ca_system_score_gemma":0.0001344839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002485696,"about_ca_topic_score_gemma":0.00001291956,"domain_scores_codex":[0.9948335,0.000874814,0.002432083,0.0009394274,0.0001270655,0.0007930695],"domain_scores_gemma":[0.9977612,0.0006734771,0.0005603399,0.0008190363,0.0001660015,0.0000198744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01466722,0.05300542,0.1286168,0.00001510915,0.000244421,0.00002198671,0.001743365,0.000006864444,0.7874975,0.0001400241,0.000003948201,0.01403737],"study_design_scores_gemma":[0.08881702,0.01426359,0.8694871,0.0001756329,0.00005751763,0.00003069509,0.001455444,0.000002692908,0.02426737,0.000009197531,0.0008339047,0.000599848],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815845,0.01594462,0.00002048415,0.00008806046,0.000468526,0.001473122,0.00006800507,0.00005590901,0.0002967258],"genre_scores_gemma":[0.9993402,0.0002114999,0.00003137965,0.00006952659,0.000003358803,0.00005463722,0.0001043824,0.00004398094,0.0001409768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7632301,"threshold_uncertainty_score":0.9998711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02308697521316649,"score_gpt":0.3311179080327173,"score_spread":0.3080309328195508,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}